Market-Moving News for July 10th
Market-Moving News for July 10th
VVPR: 119% | VivoPower Secures Amendment And Extension To $34M Shareholder Loan Financing Agreement Following Negotiations With Independent Directors Of AWN Holdings Limited
VVPR: 119% | vivopower与AWN Holdings Limited独立董事进行谈判后，成功获得了3400万美元股东贷款融资协议的修订和延期。
VRPX: 84% | Virpax Announces Results For A Swine Model Pilot Study For Probudur, Virpax's Long-acting Liposomal Bupivacaine Formulation Injected At A Wound Site To Provide Both Immediate And Extended Pain Relief
VRPX: 84% | Virpax宣布对猪模型试验的结果，采用Probudur，即Virpax的长效脂质体布比卡因制剂注射于伤口处，可提供即刻和长效止痛缓解。
LGVN: 52% | Longeveron Announces U.S. FDA Grants Lomecel-B Regenerative Medicine Advanced Therapy (RMAT) Designation For Treatment Of Mild Alzheimer's Disease
LGVN: 52% | Longeveron宣布，该公司的 Alzheimer病轻度治疗药物Lomecel-b已被美国FDA授予再生医学先进疗法(RMAT)认证。